CNS & Neurological Disorders - Drug Targets
Title: Editorial [Hot topic: New Frontiers in G Protein-Coupled Receptor Regulation of Neurological Disorders (Guest Editor: Stuart Maudsley)]
Volume: 9 Issue: 5
Author(s): Stuart Maudsley
Affiliation:
Export Options
About this article
Cite this article as:
Maudsley Stuart, Editorial [Hot topic: New Frontiers in G Protein-Coupled Receptor Regulation of Neurological Disorders (Guest Editor: Stuart Maudsley)], CNS & Neurological Disorders - Drug Targets 2010; 9 (5) . https://dx.doi.org/10.2174/187152710793361540
DOI https://dx.doi.org/10.2174/187152710793361540 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Anionic Linear Globular Dendrimer-G2-Ciprofloxacin Nano-Conjugate: Novel Agent against Wilson Disease Cell Model
Letters in Drug Design & Discovery Peeking into the Black Box: How Cytokine Antibody Arrays Shed Light on Molecular Mechanisms of Breast Cancer Development and its Treatment
Current Proteomics Incorporation of Natural Renewable Components and Waste Byproducts to Benzoxazine Based High Performance Materials
Current Organic Chemistry Glutamate-Modulating Drugs as a Potential Therapeutic Strategy in Obsessive-Compulsive Disorder
Current Neuropharmacology Dopamine Pharmacological Agents in Resistant-OCD
Current Psychopharmacology Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder
Current Neuropharmacology In Vivo Bio-imaging Using Chlorotoxin-based Conjugates
Current Pharmaceutical Design FDG-PET in the Evaluation of Brain Metabolic Changes Induced by Cognitive Stimulation in aMCI Subjects
Current Radiopharmaceuticals Separating Fact from Fiction: Assessing the Potential of Modified Adenovirus Vectors for Use in Human Gene Therapy
Current Gene Therapy Human Cognition Assessment in Drug Research
Current Pharmaceutical Design Combination of P300 and CSF β-Amyloid(1-42) Assays May Provide a Potential Tool in the Early Diagnosis of Alzheimers Disease
Current Alzheimer Research Fluorescent Probes for Cellular Assays
Combinatorial Chemistry & High Throughput Screening Cognitive Impairment with Vascular Impairment and Degeneration
Current Neurovascular Research Common Variants in Toll-Like Receptor 4 Confer Susceptibility to Alzheimer’s Disease in a Han Chinese Population
Current Alzheimer Research Post Traumatic Lesion absence of β-Dystroglycan-Immunopositivity in Brain Vessels Coincides with the Glial Reaction and the Immunoreactivity of Vascular Laminin
Current Neurovascular Research Machine Learning and Social Network Analysis Applied to Alzheimer's Disease Biomarkers
Current Topics in Medicinal Chemistry A Potential Contribution of Chemokine Network Dysfunction to the Depressive Disorders
Current Neuropharmacology Blocking Striatal Adenosine A2A Receptors: A New Strategy for Basal Ganglia Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Binding Sites of Amyloid β-Peptide in Cell Plasma Membrane and Implications for Alzheimers Disease
Current Protein & Peptide Science (Neuro)Transmitter Systems in Circulating Immune Cells: A Target of Immunopharmacological Interventions?
Current Medicinal Chemistry